Alkermes (ALKS) EPS (Basic) Growth (5y) (2015 - 2026)
Alkermes (ALKS) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.57% |
| Mar 31, 2026 | -23.30% |
| Dec 31, 2025 | 25.53% |
| Dec 31, 2024 | -43.72% |
| Sep 30, 2024 | 61.24% |
| Jun 30, 2024 | 38.65% |
| Mar 31, 2024 | 52.46% |
| Dec 31, 2023 | -32.35% |
| Sep 30, 2023 | -4.18% |
| Jun 30, 2023 | -3.76% |
| Mar 31, 2023 | 11.38% |
| Dec 31, 2022 | 59.76% |
| Sep 30, 2022 | -10.53% |
| Jun 30, 2022 | 8.08% |
| Mar 31, 2022 | 13.30% |
| Dec 31, 2021 | 49.97% |
| Sep 30, 2021 | 15.36% |
| Jun 30, 2021 | 15.41% |
| Mar 31, 2021 | 22.84% |
| Dec 31, 2020 | 10.40% |